Lin YC - Search Results

1

Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor.

Huang LK, Lin YC, Chuang HH, Chuang CK, Pang ST, Wu CT, Chang YH, Yu KJ, Lin PH, Kan HC, Chu YC, Hung WK, Hsieh ML, Shao IH. Huang LK, et al. Among authors: lin ph, lin yc. Front Oncol. 2023 Aug 10;13:1180888. doi: 10.3389/fonc.2023.1180888. eCollection 2023. Front Oncol. 2023. PMID: 37637042 Free PMC article.

2

A Muscle Biosignature Differentiating Between Limb-Girdle Muscular Dystrophy and Idiopathic Inflammatory Myopathy on Magnetic Resonance Imaging.

Hsu WC, Lin YC, Chuang HH, Yeh KY, Chan WP, Ro LS. Hsu WC, et al. Among authors: lin yc. Front Neurol. 2021 Dec 20;12:783095. doi: 10.3389/fneur.2021.783095. eCollection 2021. Front Neurol. 2021. PMID: 34987467 Free PMC article.

3

Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors.

Hsu PC, Huang CY, Lin YC, Lee SH, Chiu LC, Wu CE, Kuo SC, Ju JS, Huang AC, Ko HW, Wang CC, Yang CT. Hsu PC, et al. Among authors: lin yc. Front Oncol. 2023 Oct 3;13:1249106. doi: 10.3389/fonc.2023.1249106. eCollection 2023. Front Oncol. 2023. PMID: 37854677 Free PMC article.

4

Survival-associated factors of first-line EGFR-tyrosine kinase inhibitor responders and non-responders in lung adenocarcinoma patients with common EGFR mutations.

Hung MS, Fang YH, Lin YC, Lung JH, Hsieh MJ, Tsai YH. Hung MS, et al. Among authors: lin yc. Mol Clin Oncol. 2018 Mar;8(3):421-428. doi: 10.3892/mco.2018.1550. Epub 2018 Jan 10. Mol Clin Oncol. 2018. PMID: 29456848 Free PMC article.

5

Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy.

Lin YC, Wang CH, Ling HH, Pan YP, Chang PH, Chou WC, Chen FP, Yeh KY. Lin YC, et al. Biomedicines. 2022 Feb 6;10(2):388. doi: 10.3390/biomedicines10020388. Biomedicines. 2022. PMID: 35203597 Free PMC article.

6

Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.

Lee SH, Lin YC, Chiu LC, Ju JS, Tung PH, Huang AC, Li SH, Fang YF, Chen CH, Kuo SC, Wang CC, Yang CT, Hsu PC. Lee SH, et al. Among authors: lin yc. Ther Adv Med Oncol. 2022 Jul 23;14:17588359221113278. doi: 10.1177/17588359221113278. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35898964 Free PMC article.

7

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation.

Ko HW, Shie SS, Wang CW, Chiu CT, Wang CL, Yang TY, Chou SC, Liu CY, Kuo CS, Lin YC, Li LF, Yang CT, Wang CC. Ko HW, et al. Among authors: lin yc. Front Immunol. 2022 Oct 20;13:1011092. doi: 10.3389/fimmu.2022.1011092. eCollection 2022. Front Immunol. 2022. PMID: 36341427 Free PMC article.

8

Clinical outcome analysis of non-small cell lung cancer patients with brain metastasis receiving metastatic brain tumor resection surgery: a multicenter observational study.

Hsu PC, Chiu LC, Chen KT, Wang CC, Wu CT, Wu CE, Ko HW, Kuo SC, Lin YC, Wang CC, Yang CT. Hsu PC, et al. Among authors: lin yc. Am J Cancer Res. 2023 Aug 15;13(8):3607-3617. eCollection 2023. Am J Cancer Res. 2023. PMID: 37693127 Free PMC article.

9

Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.

Lin YC, Lin CK, Tsai YH, Weng HH, Li YC, You L, Chen JK, Jablons DM, Yang CT. Lin YC, et al. Among authors: lin ck. Oncol Rep. 2010 Dec;24(6):1605-12. doi: 10.3892/or_00001024. Oncol Rep. 2010. PMID: 21042758

10

Epidermal growth factor receptor mutation enhances expression of vascular endothelial growth factor in lung cancer.

Hung MS, Chen IC, Lin PY, Lung JH, Li YC, Lin YC, Yang CT, Tsai YH. Hung MS, et al. Among authors: lin yc, lin py. Oncol Lett. 2016 Dec;12(6):4598-4604. doi: 10.3892/ol.2016.5287. Epub 2016 Oct 18. Oncol Lett. 2016. PMID: 28101216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,257 results

Search Page